Send to a Friend
What's in a Name? Consumer Reaction to Supplements Versus Drugs
From:
To:
(subscription not required for recipient)
Enter a personalized message:
[Begin Message]
Message Body:
******************************** What's in a Name? Consumer Reaction to Supplements Versus Drugs http://knowledge.wharton.upenn.edu/index.cfm?fa=viewfeature&id=1479 When consumers are diagnosed with a medical condition such as high cholesterol or obesity, they immediately begin a new regime of brisk walks and a diet of heart-healthy foods, right? Not necessarily, says Wharton marketing professor Lisa E. Bolton. If those consumers are taking a prescription or over-the-counter drug for their condition, they may actually toss back more chips and donuts. Those taking a supplement, however, may be more likely to eat broccoli and hit the treadmill. In a new research paper, Bolton, Wharton marketing professor Americus Reed II, and Penn medical school professors Kevin G. Volpp and Katrina Armstrong look at how consumer perceptions of supplements and prescription drugs can affect risk perceptions and intentions to diet and exercise.
Finance and Investment
Leadership and Change
Executive Education
Marketing
Insurance and Pensions
Health Economics
Strategic Management
Real Estate
Law and Public Policy
Human Resources
Business Ethics
Innovation and Entrepreneurship
Operations Management
Managing Technology
Knowledge@Wharton
Visit The Wharton School of the University of Pennsylvania
Return to Home Page
Special Sections
Podcasts
Sponsors
News Room
Knowledge
Today
Feedback
Home
